Home / Inspections / 1170444

FDA Inspection 1170444 — Mylan Pharmaceuticals Inc

Mylan Pharmaceuticals Inc — FEI 1110315

The FDA completed an inspection of Mylan Pharmaceuticals Inc on May 26, 2022 in Morgantown, WV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 26, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morgantown, WV (United States)

Facility

Other inspections at this facility

  • 1311680 (NAI Tue Apr 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219018 (NAI Fri Aug 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099590 (VAI Thu Aug 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1076082 (NAI Fri Nov 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1072148 (NAI Wed Nov 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources